These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 212736)

  • 21. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M; Alarcón MA; González H; Sánchez R
    Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships amongst beta-lactamase inhibitors.
    Reading C; Cole M
    J Enzyme Inhib; 1986; 1(2):83-104. PubMed ID: 3334242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of Bacillus cereus 569/H beta-lactamase I by 6-beta-(trifluoromethane sulfonyl)amidopenicillanic acid sulfone and its N-methyl derivative.
    Clarke AJ; Mezes PS; Vice SF; Dmitrienko GI; Viswanatha T
    Biochim Biophys Acta; 1983 Nov; 748(3):389-97. PubMed ID: 6315063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
    Yamabe S
    J Antimicrob Chemother; 1980 May; 6(3):420-1. PubMed ID: 6249784
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W
    Chemotherapy; 1990; 36(3):200-8. PubMed ID: 2159863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors.
    Chen YL; Chang CW; Hedberg K; Guarino K; Welch WM; Kiessling L; Retsema JA; Haskell SL; Anderson M; Manousos M
    J Antibiot (Tokyo); 1987 Jun; 40(6):803-22. PubMed ID: 3497142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of 6-beta-bromopenicillanic acid (brobactam) in human serum by high-performance liquid chromatography (HPLC) using solid phase extraction for sample preparation.
    Woodcock JM; Wolstenholme MR; Andrews JM; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):157-61. PubMed ID: 8157556
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic.
    Fukagawa Y; Takei T; Ishikura T
    Biochem J; 1980 Jan; 185(1):177-85. PubMed ID: 6246876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
    Gottstein WJ; Crast LB; Graham RG; Haynes UJ; McGregor DN
    J Med Chem; 1981 Dec; 24(12):1531-4. PubMed ID: 6273562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid.
    Knott-Hunziker V; Waley SG; Orlek BS; Sammes PG
    FEBS Lett; 1979 Mar; 99(1):59-61. PubMed ID: 220094
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide.
    Knight GC; Waley SG
    Biochem J; 1985 Jan; 225(2):435-9. PubMed ID: 2983675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible inhibitors of penicillinases.
    Kiener PA; Waley SG
    Biochem J; 1978 Jan; 169(1):197-204. PubMed ID: 415738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.
    Chang SC; Hsu LY; Luh KT; Hsieh WC
    J Formos Med Assoc; 1991 Oct; 90(10):947-52. PubMed ID: 1685175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A semi-synthetic penicillinase inactivator.
    Cartwright SJ; Coulson AF
    Nature; 1979 Mar; 278(5702):360-1. PubMed ID: 218114
    [No Abstract]   [Full Text] [Related]  

  • 36. The beta-lactamase of Streptomyces cacaoi: interaction with cefoxitin and beta-iodopenicillanate.
    Lenzini MV; Frère JM
    J Enzyme Inhib; 1985; 1(1):25-34. PubMed ID: 2854843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP; Ho SW; Luh KT; Hsieh WC
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].
    Jarlier V
    Presse Med; 1998 Sep; 27 Suppl 4():17-8. PubMed ID: 9798480
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.